Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / cardiol therapeutics begins phase ii study of cardio

CRDL - Cardiol Therapeutics begins Phase II study of CardiolRx for treatment of recurrent pericarditis

Cardiol Therapeutics Inc.

(NewsDirect)

ContactDetails

Proactive Canada

ProactiveCanada

+1 604-688-8158

na-editorial@proactiveinvestors.com

Copyright (c) 2022 TheNewswire - All rights reserved.

Stock Information
Company Name: Cardiol Therapeutics Inc.
Stock Symbol: CRDL
Market: NASDAQ
Menu
CRDL CRDL Quote CRDL Short CRDL News CRDL Articles CRDL Message Board
Get CRDL Alerts

News, Short Squeeze, Breakout and More Instantly...